Vitor Won-Held Rabelo

12PUBLICATIONS
41CO-AUTHORS
Medical infection agents (incl. prions)Forest health and pathologyMolecular targetsCheminformatics and quantitative structure-activity relationshipsTransgenesis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 26, 2026
Acetohydroxyacid Synthase (AHAS) as a Promising and Underexplored Target for the Development of New Antifungal Agents.

João Pedro Neves de Mello, Vitor Won-Held Rabelo, Daiane de Jesus Viegas

|Sep 22, 2025
Mechanistic Insights into the Anticancer Action of Novel 2‑Hydroxy-1,4-naphthoquinone Thiol Derivatives.

Thaís Barreto Santos, Alex de Souza Cruz Lopes Canuto, João Francisco Blaudt Virgilio de Carvalho Meira

|Sep 18, 2024
β-enaminoester derivatives exhibit promising in vitro and in silico antiviral potential against Mayaro virus.

Natasha Cristina da Rocha, Leonardo Dos Santos Corrêa Amorim, Vitor Won-Held Rabelo

|Jul 01, 2024
In Silico Drug Repurposing Uncovered the Antiviral Potential of the Antiparasitic Drug Oxibendazole Against the Chikungunya Virus.

Vitor W Rabelo, Maria Leonisa Sanchez-Nuñez, Leonardo S Corrêa-Amorim

|May 27, 2024
Antiviral Activity of <i>Kappaphycus alvarezii</i> Seaweed against ZIKV.

Caroline de S Barros, Claudio C Cirne-Santos, Priscilla O Esteves

Pageof 2